Navigation Links
Pluromed, Inc. Signs Agreement with Boston Scientific
Date:10/8/2009

Boston Scientific to distribute Pluromed's BackStop™ device, a rapid phase transition gel used in the treatment of Kidney Stones.

Woburn, Massachusetts (PRWEB) October 9, 2009 -- Pluromed, Inc. has announced that it has entered into an alliance with Boston Scientific Corporation (NYSE: BSX) regarding Pluromed's BackStop™ product, a device used in ureteroscopic kidney stone management procedures. Boston Scientific has acquired the worldwide distribution rights to BackStop. The financial terms of the agreement were not disclosed.

Kidney stone disease is estimated to affect millions of people worldwide. A common method of treating these stones is intracorporeal lithotripsy where the stones are fragmented using a laser or other energy modality in a minimally invasive procedure. Backstop™ is based on Pluromed's proprietary Rapid Transition Polymers™ (RTP™) that are liquid at low temperature and transition to a gel at body temperature; the transition is reversible via cooling and the gel is completely dissolvable. The BackStop gel forms a plug above the stones in the ureter and is designed to prevent stone migration during the procedure. After stone fragmentation is complete, the gel is dissolved with saline and exits the body. The BackStop product offers the potential to reduce operating time and complexity, and improve "stone free" rates for patients.

"We are very pleased to work with with Boston Scientific," said John Merhige, Pluromed's Vice President of Market Development. "BSC is the market leader with the resources and expertise to get the BackStop product into the hands of urologists." The BackStop device is approved for sale in Europe, Canada and the United States.

Jean-Marie Vogel, Pluromed's CEO, said, "This alliance represents an important event in the evolution of Pluromed. The proceeds from the agreement allow us to further invest in growing our core cardiovascular business, and with Boston Scientific distributing the BackStop product, we anticipate a successful launch and ongoing growth."

Pluromed and Boston Scientific will be working closely on integrating the BackStop product into BSC's systems in anticipation of the worldwide product launch.


About Pluromed, Inc.
Pluromed, Inc., Woburn, Massachusetts, founded in 2003, is pioneering the use of atraumatic gel plugs to improve the safety, efficacy and economics of medical interventions. These products address a broad surgery market that includes cardiac and vascular surgery, prostate, kidney and liver surgery, plastic/reconstructive surgery, trauma/battlefield applications and the treatment of kidney stones. They are based on the Company's patented rapid phase transition polymer technology; Pluromed Rapid Transition Polymers™ (RTP™) are liquid at low temperature and quickly transition to a high viscosity gel at body temperature. For more information, please visit www.pluromed.com

About Boston Scientific Corporation
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb3011074.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. SEO Consultant Top Rank Web Designs Gives Away 250 Free Websites
2. /R E P E A T -- DiagnoCure signs distribution agreement in the UK for its colorectal cancer test/
3. DiagnoCure signs distribution agreement in the UK for its colorectal cancer test
4. AdaptaVan, LLC Signs Two New Dealers: Company's Wheelchair Accessible Vans Now Available in North Carolina and Missouri
5. The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions
6. Rapid Fire Marketing Signs 5 Year Agreement
7. Osseon Signs International Distribution Agreement With MBA Incorporado
8. New device finds early signs of eye disease in preemies
9. GENova Biotherapeutics signs LOI with Korean university for stem cell research and patents sharing
10. GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited
11. Haemonetics Signs Comprehensive Agreement with Blood Centers of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: